A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

C. Pellegrini; A. Dodero; Annalisa Chiappella; F. Monaco; D. Degl'Innocenti; F. Salvi; U. Vitolo; Lisa Argnani; P. Corradini; Pier Luigi Zinzani

doi:10.1186/s13045-016-0266-1

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

C. Pellegrini, A. Dodero, Annalisa Chiappella, F. Monaco, D. Degl'Innocenti, F. Salvi, U. Vitolo, Lisa Argnani, P. Corradini, Pier Luigi Zinzani

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Journal of Hematology and Oncology
Volume	9
Issue number	1
DOIs	https://doi.org/10.1186/s13045-016-0266-1
Publication status	Published - 2016

Access to Document

10.1186/s13045-016-0266-1

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007566203&doi=10.1186%2fs13045-016-0266-1&partnerID=40&md5=138e6a93fb51b515e69b700f3f9ca8f6

Cite this

Pellegrini, C., Dodero, A., Chiappella, A., Monaco, F., Degl'Innocenti, D., Salvi, F., Vitolo, U., Argnani, L., Corradini, P., & Zinzani, P. L. (2016). A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients. Journal of Hematology and Oncology, 9(1). https://doi.org/10.1186/s13045-016-0266-1

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients. / Pellegrini, C.; Dodero, A.; Chiappella, Annalisa; Monaco, F.; Degl'Innocenti, D.; Salvi, F.; Vitolo, U.; Argnani, Lisa; Corradini, P.; Zinzani, Pier Luigi.

In: Journal of Hematology and Oncology, Vol. 9, No. 1, 2016.

Research output: Contribution to journal › Article › peer-review

Pellegrini, C , Dodero, A, Chiappella, A, Monaco, F , Degl'Innocenti, D , Salvi, F, Vitolo, U, Argnani, L, Corradini, P & Zinzani, PL 2016, 'A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients', Journal of Hematology and Oncology, vol. 9, no. 1. https://doi.org/10.1186/s13045-016-0266-1

Pellegrini, C. ; Dodero, A. ; Chiappella, Annalisa ; Monaco, F. ; Degl'Innocenti, D. ; Salvi, F. ; Vitolo, U. ; Argnani, Lisa ; Corradini, P. ; Zinzani, Pier Luigi. / A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients. In: Journal of Hematology and Oncology. 2016 ; Vol. 9, No. 1.

@article{4d2af005ec084c3d948e1dd5fbcf1247,

title = "A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients",

author = "C. Pellegrini and A. Dodero and Annalisa Chiappella and F. Monaco and D. Degl'Innocenti and F. Salvi and U. Vitolo and Lisa Argnani and P. Corradini and Zinzani, {Pier Luigi}",

note = "Cited By :2 Export Date: 8 March 2017",

year = "2016",

doi = "10.1186/s13045-016-0266-1",

language = "English",

volume = "9",

journal = "Journal of Hematology and Oncology",

issn = "1756-8722",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

AU - Pellegrini, C.

AU - Dodero, A.

AU - Chiappella, Annalisa

AU - Monaco, F.

AU - Degl'Innocenti, D.

AU - Salvi, F.

AU - Vitolo, U.

AU - Argnani, Lisa

AU - Corradini, P.

AU - Zinzani, Pier Luigi

N1 - Cited By :2 Export Date: 8 March 2017

PY - 2016

Y1 - 2016

U2 - 10.1186/s13045-016-0266-1

DO - 10.1186/s13045-016-0266-1

M3 - Article

VL - 9

JO - Journal of Hematology and Oncology

JF - Journal of Hematology and Oncology

SN - 1756-8722

IS - 1

ER -